PT1015433E - 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua producao e sua utilizacao como medicamentos - Google Patents

1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua producao e sua utilizacao como medicamentos

Info

Publication number
PT1015433E
PT1015433E PT98950009T PT98950009T PT1015433E PT 1015433 E PT1015433 E PT 1015433E PT 98950009 T PT98950009 T PT 98950009T PT 98950009 T PT98950009 T PT 98950009T PT 1015433 E PT1015433 E PT 1015433E
Authority
PT
Portugal
Prior art keywords
benzazocin
hexa
hydro
medicines
methane
Prior art date
Application number
PT98950009T
Other languages
English (en)
Inventor
Wolf-Dietrich Bechtel
Thomas Weiser
Rainer Palluk
Matthias Grauert
Adrian Carter
Uwe Pschorn
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT1015433E publication Critical patent/PT1015433E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT98950009T 1997-09-12 1998-09-09 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua producao e sua utilizacao como medicamentos PT1015433E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19740110A DE19740110A1 (de) 1997-09-12 1997-09-12 Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
PT1015433E true PT1015433E (pt) 2004-08-31

Family

ID=7842134

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98950009T PT1015433E (pt) 1997-09-12 1998-09-09 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua producao e sua utilizacao como medicamentos

Country Status (38)

Country Link
US (1) US6455538B1 (pt)
EP (1) EP1015433B1 (pt)
JP (1) JP3827528B2 (pt)
KR (1) KR100601008B1 (pt)
CN (1) CN1166640C (pt)
AR (1) AR017095A1 (pt)
AT (1) ATE267811T1 (pt)
AU (1) AU751036B2 (pt)
BG (1) BG64418B1 (pt)
BR (1) BR9812443A (pt)
CA (1) CA2302347C (pt)
CO (1) CO5011117A1 (pt)
CZ (1) CZ296909B6 (pt)
DE (2) DE19740110A1 (pt)
DK (1) DK1015433T3 (pt)
EE (1) EE04398B1 (pt)
ES (1) ES2222612T3 (pt)
HR (1) HRP980502B1 (pt)
HU (1) HUP0004588A3 (pt)
ID (1) ID24173A (pt)
IL (1) IL134572A (pt)
MY (1) MY120550A (pt)
NO (1) NO315650B1 (pt)
NZ (1) NZ503710A (pt)
PE (1) PE122899A1 (pt)
PL (1) PL198486B1 (pt)
PT (1) PT1015433E (pt)
RS (1) RS49888B (pt)
RU (1) RU2218334C2 (pt)
SA (1) SA98190765B1 (pt)
SK (1) SK284670B6 (pt)
TR (1) TR200000697T2 (pt)
TW (1) TW505645B (pt)
UA (1) UA61973C2 (pt)
UY (2) UY25175A1 (pt)
WO (1) WO1999014199A1 (pt)
YU (1) YU12000A (pt)
ZA (1) ZA988285B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826365A1 (de) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Verwendung von Benzomorphanderivaten als Analgetikum
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
DE19957156A1 (de) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
DE10204276A1 (de) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6683089B2 (en) 2002-02-02 2004-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols
DE10223783A1 (de) * 2002-05-29 2003-12-11 Boehringer Ingelheim Pharma Neue Formulierung zur parenteralen Applikation eines Na-Kanal-Blockers
US6828311B2 (en) 2002-05-29 2004-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Formulation for the parenteral application of a sodium channel blocker
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
US20030235576A1 (en) * 2002-06-15 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations for the treatment of ischaemic conditions
DE10226814A1 (de) * 2002-06-15 2004-01-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung ischämischer Zustände
SI1963280T1 (sl) 2005-12-22 2016-02-29 Newron Pharmaceuticals S.P.A. 2-feniletilamino derivati kot modulatorji kalcijevih in/ali natrijevih kanalčkov
EA018195B1 (ru) 2007-06-15 2013-06-28 Ньюрон Фармасьютикалс С.П.А. Замещенные 2-[2-(фенил)этиламино]алканамидные производные и применение указанных соединений в качестве модуляторов натриевых и/или кальциевых каналов
EP2723710B1 (en) 2011-06-27 2016-08-10 Newron Pharmaceuticals S.p.A. Fluorinated arylalkylaminocarboxamide derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
US4208523A (en) * 1978-11-30 1980-06-17 Sterling Drug Inc. 11-Lower-alkyl-, 11-phenyl-lower-alkyl- and 11-cyclo-lower-alkyl-lower-alkyl-hexahydro-2,6-methano-3-benzazocines
US5607941A (en) * 1992-06-26 1997-03-04 Boehringer Ingelheim Kg Useful for treating neurodegenerative diseases
DE4121821A1 (de) * 1991-07-02 1993-01-14 Boehringer Ingelheim Kg Neue benzomorphane und ihre verwendung als arzneimittel
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan

Also Published As

Publication number Publication date
UY25439A1 (es) 1999-11-17
WO1999014199A1 (de) 1999-03-25
IL134572A (en) 2005-05-17
KR100601008B1 (ko) 2006-07-19
SK284670B6 (sk) 2005-08-04
SK3342000A3 (en) 2000-09-12
AU9624298A (en) 1999-04-05
BR9812443A (pt) 2000-09-26
AR017095A1 (es) 2001-08-22
HRP980502B1 (en) 2005-02-28
PL339061A1 (en) 2000-12-04
YU12000A (sh) 2002-11-15
ID24173A (id) 2000-07-13
EP1015433A1 (de) 2000-07-05
ZA988285B (en) 1999-03-12
RU2218334C2 (ru) 2003-12-10
SA98190765B1 (ar) 2006-06-10
KR20010023879A (ko) 2001-03-26
IL134572A0 (en) 2001-04-30
CZ296909B6 (cs) 2006-07-12
CZ2000894A3 (cs) 2000-09-13
RS49888B (sr) 2008-08-07
EE200000129A (et) 2001-02-15
DK1015433T3 (da) 2004-09-27
TW505645B (en) 2002-10-11
NO20001288L (no) 2000-03-13
DE59811477D1 (de) 2004-07-01
AU751036B2 (en) 2002-08-08
NO315650B1 (no) 2003-10-06
HUP0004588A3 (en) 2002-10-28
MY120550A (en) 2005-11-30
ES2222612T3 (es) 2005-02-01
NZ503710A (en) 2002-04-26
PL198486B1 (pl) 2008-06-30
UY25175A1 (es) 2000-12-29
PE122899A1 (es) 1999-12-06
CA2302347C (en) 2008-06-17
CO5011117A1 (es) 2001-02-28
CA2302347A1 (en) 1999-03-25
CN1166640C (zh) 2004-09-15
ATE267811T1 (de) 2004-06-15
UA61973C2 (en) 2003-12-15
HRP980502A2 (en) 1999-06-30
EP1015433B1 (de) 2004-05-26
BG104232A (en) 2000-10-31
CN1269790A (zh) 2000-10-11
DE19740110A1 (de) 1999-03-18
JP2001516747A (ja) 2001-10-02
EE04398B1 (et) 2004-12-15
BG64418B1 (bg) 2005-01-31
HUP0004588A2 (hu) 2001-07-30
JP3827528B2 (ja) 2006-09-27
US6455538B1 (en) 2002-09-24
TR200000697T2 (tr) 2001-01-22
NO20001288D0 (no) 2000-03-10

Similar Documents

Publication Publication Date Title
PT1086092E (pt) Derivados de 1,1-dioxido-benzo (b) tiepina processo para a sua producao medicamentos contendo esses compostos e a sua utilizacao
BR9707839A (pt) Primido-Ú5,4-D¾-primidas medicamentos contendo esses compostos sua aplicação e processo para a sua preparação
BR9402517A (pt) Silanos, processo para a sua fabricação e sua utilização
BR9807845B1 (pt) pó de tántalo e processo para a sua produção.
PT1076657E (pt) Novos hidroxi-indoles, sua utilizacao como inibidores da fosfodiesterase 4 e processo para a sua producao
PT1325001E (pt) Novos anticolinergicos aplicaveis como medicamentos e processo para a sua preparacao
BR9804378B1 (pt) compostos, processo para sua produção e uso.
PT1218341E (pt) Derivados de sulfonilcarboxamidas, processo para a sua preparacao e sua utilizacao como medicamentos
PT1124810E (pt) Derivados 2-amino-tiazole, processo para a sua preparacao e sua utilizacao como agentes anti-tumorais
BR9605354A (pt) Composto composição farmacêutica processo para a produção do composto e uso
PT983059E (pt) Processo para a producao de pastilhas de flurbiprofeno
PT1038899E (pt) PROMOTOR DE ADESAO PARA REFORCOS TêXTEIS INTERNOS PROCESSO PARA A SUA PRODUCAO E A SUA UTILIZACAO
PT1233763E (pt) Sistemas terapeuticos transdermicos com estabilidade melhorada e um processo para a sua producao
PT1016740E (pt) Fibra precursora baseada em acrilonitrilo para fibras de carbono, processo para a sua producao, e sua utilizacao na formacao de uma fibra de carbono
PT1015433E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua producao e sua utilizacao como medicamentos
BR9509842A (pt) Processo para produção de fosgênio
BR9104948A (pt) Compostos,processo para a sua producao,agente farmaceutico e processo para a sua producao
PT903339E (pt) Bifenilsulfonilcianamidas processos para a sua preparacao e sua utilizacao como medicamentos
BR9101488A (pt) Preparados de lipossomas,sua utilizacao e processo para a sua producao
BR9602789A (pt) Processo para a produção de aminas aromáticas e catalisador
PT1027315E (pt) Processo para a producao de n-butanol.
PT1015421E (pt) Novos derivados de fenilamidina processo para a sua preparacao e sua utilizacao como medicamentos
PT1098891E (pt) Aminas tiazolidin-2-ilideno policiclicas processo para a sua preparacao e sua utilizacao como medicamento
BR9804873A (pt) Processo para a produ-Æo de ironas
BR9814774B1 (pt) processo para a preparação de (-)cis-3-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-piperidi na e intermediários para sua preparação.